Approval · Notice of Compliance 7972 · 2006
FLAGYSTATIN: Notice of Compliance 7972
Issued May 17, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7972
- Date
- May 17, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Trichomonacide - moniliacide
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLAGYSTATIN | 01926845 | Cancelled Post Market |
| FLAGYSTATIN | 01926829 | Marketed |
Medicinal ingredients
- NYSTATIN 100,000 UNIT per SUP
- METRONIDAZOLE 500 MG per SUP
- METRONIDAZOLE 500 MG per 4.5G
- NYSTATIN 100,000 UNIT per 4.5G